A strong team of executives and scientists with long-term pharmaceutical and healthcare industry experience, which encompasses research discovery and development, finance and business development, contributes towards SEEK successful progress.
Roderick (“Rod”) Bransgrove is an extremely successful pharmaceutical executive and highly experienced company chairman. He joined Schering Chemicals Limited (the UK subsidiary of Schering AG) in 1972 and completed a dynamic career path through the Marketing and Sales disciplines and was appointed General Manager of the Pharmaceutical Business in 1985. In 1986, he founded Imperial Pharmaceutical Services Limited which merged with Shire Pharmaceuticals Ltd to form Shire Pharmaceuticals Group plc (“Shire”) in 1995 and was listed on the London Stock Exchange the following year. From 1995-1998 Rod remained a Non-Executive Director of Shire. In 1998, he led the successful takeover of LSE-listed Sleepy Kids plc to establish Entertainment Rights plc, a company specialising in the commercialisation of intellectual property rights and children’s television characters. In October, 2000, Rod also became Chairman of RB Sport & Leisure Holdings plc (then Rose Bowl plc), which incorporated Hampshire Cricket Limited, and remains Chairman of this diverse Group to this day. He served as a Director of the England and Wales Cricket Board (ECB) from 2003-2005 and holds non-executive directorships in Cage Cricket Ltd and MusicPlanetLive Ltd as well as PepTcell Ltd.
John Hardy has a scientific background and a career in film finance and the advisory area of investment banks, ultimately being a shareholder in a listed investment bank, which he was involved in creating. John is currently involved in the provision of complex funding with particular emphasis on structured finance.
Feroze Janmohamed has a pharmaceutical background and currently co invests with Roderick Bransgrove in a number of different opportunities including medical scientific entities.
Kim Duncan has 20 years’ experience in the investment business. After graduating from Yale University with a BSc in Electrical Engineering, Kim began his career as a trader at Goldman Sachs in 1987. From there, he went on to Nomura, Credit Suisse and Mizuho, leading teams conducting principal investment activities in which the firms’ capital was invested directly for their own account. Major transactions include the acquisitions of Inntrepreneur Pub chain, Ange l Trains, AT&T Capital, and Stenvalvet AB. Kim has extensive experience in structured finance, leveraged finance and credit derivatives trading. As well as SEEK, Kim sits on the boards of various early stage ventures including Curemark LLP, Pharmajet Inc. and Flying Aces Limited.
Chief Executive OfficerView details
Gregory Stoloff founded SEEK – formerly known as PepTcell – in 2004 after a distinguished career in investment banking spanning 20 years, working in a broad range of institutions including Deutsche Bank and UBS. He initially concentrated on corporate finance and was involved in numerous mergers and acquisitions and structured finance with an emphasis on the healthcare industry, including mergers by GlaxoSmithKline, Aventis and Pfizer. Gregory then moved on to concentrate on project finance and was involved in financings for major pharmaceutical companies such as Roche, Merck and Novartis and across various other sectors. Gregory also has a wealth of experience in advising and working with medical research companies.
Gregory is a qualified Chartered Accountant and has spent many years researching scientific medical issues, specifically related to the immune system. He has also been involved in several publications, recounting research in the peptide space and is listed as an inventor in numerous patents for cancer, HIV, mosquito-borne diseases and influenza.
Gregory has been instrumental in the development of the concepts pursued by SEEK and has been the driving force behind the Group’s continued growth and diversification.
Mohammed Al Nemer is an entrepreneur and investor. He is the founder and chief executive of Morood Invest., a multi-tiered proprietary investment management firm, focused on Private Equity and Capital Markets trading. SEEK is one of many investments in Morood’s portfolio which mainly targets promising growth companies in the healthcare, real estate, financial services, food & beverage, retail and technology sectors. Mohammed has gained intensive financial experience in corporate banking at Saudi British Bank (an affiliate of HSBC Group). He is also on the board of some Saudi companies. Mohammed was awarded a BA degree in Management Information Systems from King Fahad University of Petroleum and Minerals (Saudi) and MSc in Management from Cass Business School (London).
James Synge worked for 15 years in investment banking and auditing firms concentrating on accounting and taxation matters. He also qualified as a Chartered Accountant. James is an experienced private investor and has investments and directorships in different sectors. James was instrumental in the Group’s formation.